<DOC>
	<DOCNO>NCT00049803</DOCNO>
	<brief_summary>The initial portion protocol involve discontinue medication cataplexy patient may take . Subsequently , patient prescribe dose oral solution study drug placebo 10-11 week period . During trial , narcolepsy symptom evaluate . Participants allow continue use stimulant medication constant dos study . A total 1 3 daytime visit addition 4 overnight visit sleep center require complete study .</brief_summary>
	<brief_title>Safety Efficacy Xyrem Oral Solution ( Sodium Oxybate ) Compared With Placebo Narcoleptic Patients</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>INCLUSION CRITERIA Have sign &amp; date informed consent begin protocol procedure . Willing &amp; able complete entire trial describe protocol . 16 year age old . Have history presenting symptom excessive daytime sleepiness . Have history cataplexy localizable specific muscle group ( ) part ( ) body patient lucid ( experience inadvertent nap micro sleep ) . Have valid PSG &amp; MSLT score ( collect overnight test ) within last five year current diagnosis narcolepsy accord follow criterion establish American Sleep Disorders Association : ( 1 ) Recurrent daytime naps lapse sleep occur almost daily least 3 month ; ( 2 ) Sudden bilateral loss postural muscle tone occur association intense emotion ( cataplexy ) ; ( 3 ) Polysomnography demonstrate one following : ( ) Sleep latency le 10 minute ; ( b ) REM sleep latency le 20 minute ; ( c ) An MSLT demonstrate mean sleep latency le 5 minute ; ( ) Two sleeponset REM period Females surgically sterile , two year postmenopausal , childbearing potential , use medically accept method birth control agree continue use method duration trial . In opinion investigator , adequate support duration trial include transportation trial site . In addition , investigator ’ assessment clinically indicate , patient willing operate car heavy machinery duration trial long investigator deem clinically indicate . EXCLUSION CRITERIA Received gammahydroxybutyrate last 30 day . Have take investigational therapy within 30day period prior initial screen visit trial . Patients take fluoxetine ( Prozac ) . Have diagnose sleep apnea syndrome , define Apnea Index &gt; 10 per hour Apnea Hypopnea Index great 15 per hour , cause daytime sleepiness , disorder ( ) consider primary cause excessive daytime sleepiness . Taking hypnotic , tranquilizer , antihistamine ( except nonsedating antihistamine ) , benzodiazepine clonidine start baseline period . Patients take anticonvulsant eligible participate even willing washout anticonvulsant trial . Experiencing unstable cardiovascular , endocrine , neoplastic ( exclude localize basal cell carcinoma ) , gastrointestinal , hematologic , hepatic , immunologic , metabolic , neurological ( narcolepsy/cataplexy ) , pulmonary , and/or renal disease would place patient risk trial compromise objective outline protocol . Have psychiatric disorder , major affective psychotic disorder , problem , investigator ’ opinion , would preclude patient 's participation completion trial compromise reliable representation subjective symptom . Have current recent ( within one year ) history substance use disorder include alcohol abuse define DSMIV . Serum creatinine great 2.0 mg/dL , abnormal liver function test ( SGOT [ AST ] SGPT [ ALT ] twice upper limit normal ) , elevate serum bilirubin ( 1.5 time upper limit normal ) , pretrial ECG result demonstrate clinically significant arrhythmia , great first degree AV block history myocardial infarction within last six month . Have occupation require variable shift work routine night shift . Have clinically significant history seizure disorder , history clinically significant head trauma ( i.e. , concussion result clinically significant loss consciousness ) past invasive intracranial surgery , take anticonvulsant medication .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>Narcolepsy</keyword>
	<keyword>Sodium Oxybate</keyword>
	<keyword>Cataplexy</keyword>
	<keyword>Excessive Daytime Sleepiness</keyword>
	<keyword>GHB</keyword>
	<keyword>Gamma Hydroxybutyric Acid</keyword>
	<keyword>Orphan Medical</keyword>
	<keyword>Orphan Drug</keyword>
</DOC>